Organon OGN
NYSE OGN
$13.71 -0.03 (-0.22%)
At close: Sep 30, 2026 · 4:00 PM EDT

Organon (OGN) Divestments (2026)

Updated

Organon's Divestments came in at $433 million for Q1 2026.

Analysis

Organon (OGN) Divestments (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 87.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.88 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Organon 3.60 Bn 106.37 Mn 847.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 433.00 Mn
API Access

Organon Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=divestments&ticker=OGN&period=max&api_key=YOUR_API_KEY